Proficio Capital Partners LLC Has $495.85 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Proficio Capital Partners LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 89,098.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 949,967 shares of the medical equipment provider’s stock after buying an additional 948,902 shares during the quarter. Proficio Capital Partners LLC’s holdings in Intuitive Surgical were worth $495,845,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management boosted its stake in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC boosted its stake in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $580.93 on Thursday. The stock’s 50-day moving average is $568.10 and its 200-day moving average is $527.65. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market cap of $206.92 billion, a P/E ratio of 90.63, a P/E/G ratio of 5.85 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,240 shares of company stock worth $3,529,040 over the last ninety days. 0.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ISRG shares. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Barclays raised their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.